Evidence map›Paper›PMID 34452093›Full record

ReviewPharmaceutics2021

Translation of Polymeric Microneedles for Treatment of Human Diseases: Recent Trends, Progress, and Challenges.

Prateek Ranjan Yadav, Monika Nasrin Munni, Lauryn Campbell, Golam Mostofa, Lewis Dobson, Morayo Shittu, Sudip Kumar Pattanayek, Md Jasim Uddin, Diganta Bhusan Das

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Cleanroom-Free Fabrication of Microneedles for Multimodal Drug Delivery.Small (Weinheim an der Bergstrasse, Germany) · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Prateek Ranjan YadavDepartment of Chemical Engineering, Loughborough University, Loughborough LE11 3TU, UK.
Monika Nasrin MunniDrug Delivery & Therapeutics Lab, Dhaka 1212, Bangladesh.
Lauryn CampbellDepartment of Chemical Engineering, Loughborough University, Loughborough LE11 3TU, UK.
Golam MostofaDrug Delivery & Therapeutics Lab, Dhaka 1212, Bangladesh.ORCID 0000-0002-3869-797X
Lewis DobsonDepartment of Chemical Engineering, Loughborough University, Loughborough LE11 3TU, UK.ORCID 0000-0002-3099-6350
Morayo ShittuDepartment of Chemical Engineering, Loughborough University, Loughborough LE11 3TU, UK.
Sudip Kumar PattanayekChemical Engineering Department, Indian Institute of Technology, Delhi 110016, India.
Md Jasim UddinDrug Delivery & Therapeutics Lab, Dhaka 1212, Bangladesh.
Diganta Bhusan DasDepartment of Chemical Engineering, Loughborough University, Loughborough LE11 3TU, UK.ORCID 0000-0001-9427-6582

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ongoing search for biodegradable and biocompatible microneedles (MNs) that are strong enough to penetrate skin barriers, easy to prepare, and can be translated for clinical use continues. As such, this review paper is focused upon discussing the key points (e.g., choice polymeric MNs) for the translation of MNs from laboratory to clinical practice. The review reveals that polymers are most appropriately used for dissolvable and swellable MNs due to their wide range of tunable properties and that natural polymers are an ideal material choice as they structurally mimic native cellular environments. It has also been concluded that natural and synthetic polymer combinations are useful as polymers usually lack mechanical strength, stability, or other desired properties for the fabrication and insertion of MNs. This review evaluates fabrication methods and materials choice, disease and health conditions, clinical challenges, and the future of MNs in public healthcare services, focusing on literature from the last decade.

Indexed as

human diseasepolymeric microneedletransdermal drug deliveryvaccine delivery

Identifiers

PMID34452093
PMCPMC8401662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.